Report Code: A02242 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Cervical Cancer Drugs Market
Request Now !Cervical cancer is an uncontrolled growth of cells in the cervix region, which is accompanied by symptoms such as abnormal vaginal bleeding, pelvic pain, pain during sexual intercourse, and abnormal vaginal discharge. Anti-cancer therapy is useful in the treatment and prevention of cervical cancer. It includes surgery, radiation therapy, chemoradiation, and chemotherapy.
The global cervical cancer drugs market is driven by high prevalence of cancer, rise in incidence of HIV in women, unprotected/unsafe sex, and lack of knowledge regarding diagnostic tests for prevention of invasive cancer. However, high cost of treatment and lack of awareness about the disease in the developing nations are expected to restrain the market growth. On the contrary, proactive government initiatives to spread awareness about cervical cancer are expected to drive the market growth.
The global cervical cancer drugs market is segmented on the basis of indication, treatment type, end user, and geography. Based on disease indication, it is divided into pre-malignant lesions, early invasive stage, and advanced invasive stage. Based on the treatment type, it is classified into cryotherapy, cold knife cone biopsy simple hysterectomy, laser surgery, LEEP (loop electrosurgical excision procedure), cone biopsy, radical trachelectomy, targeted therapy, chemotherapy, radiation therapy, and hormone therapy. Based on end user, it is categorized into hospitals, cancer palliative care clinics, diagnostic centers, and pharmacies. Geographically, it is analyzed into four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include F. Hoffmann-La Roche Ltd., Hetero, GlaxoSmithKline plc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Allergan plc., Biocon Limited, Bristol-Myers Squibb Company, and Novartis AG.
Key Benefits
Cervical Cancer Drugs Market Report Highlights
Aspects | Details |
---|---|
By Disease Indication |
|
By Treatment Type |
|
By End User |
|
By Region |
|
Key Market Players | Alnylam Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Biocon Limited, Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer, Inc., Novartis AG, Allergan plc., GlaxoSmithKline plc., Hetero |
Start reading.
This Report and over 67,132+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers